Epiminder Ltd (EPI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Epiminder Ltd (EPI) has a cash flow conversion efficiency ratio of -0.342x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-34.30 Million ≈ $-24.27 Million USD) by net assets (AU$100.27 Million ≈ $70.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EPI net asset quality score to measure how much of total assets are equity-financed.
Epiminder Ltd - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Epiminder Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Epiminder Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Epiminder Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Epiminder Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EARNZ plc
LSE:EARN
|
-0.135x |
|
Sporttotal AG
F:WIG1
|
0.078x |
|
Mercantile Ports & Logistics Ltd
LSE:MPL
|
-0.010x |
|
Selina Hospitality PLC
NASDAQ:SLNAF
|
-0.016x |
|
Sound Energy PLC
LSE:SOU
|
-0.069x |
|
Oxford Biodynamics PLC
LSE:OBD
|
-2.475x |
|
Empyrean Energy Plc
LSE:EME
|
0.110x |
|
Brighton Pier Group PLC
LSE:PIER
|
0.061x |
Annual Cash Flow Conversion Efficiency for Epiminder Ltd (2023–2025)
The table below shows the annual cash flow conversion efficiency of Epiminder Ltd from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Epiminder Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$107.39 Million ≈ $75.98 Million |
AU$-16.98 Million ≈ $-12.01 Million |
-0.158x | -108.95% |
| 2024-06-30 | AU$-7.79 Million ≈ $-5.51 Million |
AU$-13.77 Million ≈ $-9.74 Million |
1.767x | +117.26% |
| 2023-06-30 | AU$1.39 Million ≈ $984.74K |
AU$-14.25 Million ≈ $-10.08 Million |
-10.239x | -- |
About Epiminder Ltd
Epiminder Limited develops and manufactures a monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. It offers Minder system, an implantable sub scalp electroencephalography (EEG) monitoring system which is designed for continuous monitoring of brain activity. The company's Minder system comprises Minder implant, a sub scalp electrode with mul… Read more